Navigation Links
Shire's New Product Portfolio Delivers Strong Quarterly Performance
Date:10/29/2008

PHILADELPHIA and DUBLIN, Ireland, Oct. 29 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, Nasdaq: SHPGY) the global specialty biopharmaceutical company announces results for the three months to September 30, 2008.

Q3 2008 Financial Highlights

- Product sales up 31% to $713 million

- Product sales excluding ADDERALL XR(R) up 51% to $444 million

- New product sales(1) $276 million, 39% of product sales (2007:

22%)

- Total revenues up 28% to $779 million

- Non GAAP earnings(2) per ADS up 88% to $1.17 (2007: $0.62)

- US GAAP earnings(2) per ADS down 62% to $0.07 (2007: $0.19)

(1) New product sales comprise DAYTRANA(R), ELAPRASE(R), FIRAZYR(R), FOSRENOL(R), LIALDA(R) / MEZAVANT(R) and VYVANSE(R)

(2) Earnings from continuing operations

Angus Russell, Chief Executive Officer, commented:

"Shire had another very strong quarter across its business. Product sales were up 31% and Non GAAP earnings per ADS rose 88%, compared with the same period last year.

"Our new products continued to underpin this growth, generating revenues of $276 million, representing 39% of our total product sales and exceeding ADDERALL XR sales for the first time. The performance of ELAPRASE, VYVANSE, LIALDA and FOSRENOL ROW were particularly strong. This quarter FIRAZYR was made available in Germany and the UK. We remain confident that these products will continue to deliver strong growth, driven in part by our geographical expansion into the important emerging markets.

"Shire remains highly cash generative, supporting the investment we continue to make in developing our substantial pipeline of products and in expanding the reach of our existing portfolio. We have a robust balance sheet, good liquidity, and strong cash flow, with $279 million of cash flows from operating activities in the third quarter alone.

"We are in a strong position as we look ahead to the end of 2008 and beyond,
'/>"/>

SOURCE Shire Plc
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related biology technology :

1. Beckman Coulter Signs Agreements with Adventist Health; Broad Product Offering Enhances Delivery of Quality Patient Care
2. PEAK Surgical Introduces PlasmaBlade(TM) Product Line Extensions for Use in General Surgery
3. Lilly Announces Launch of Color Differentiation System for Humalog(R) and Humulin(R) U-100 Insulin Products in the United States
4. GenOdyssee Receives Broad Product Applications Protection in EU for Founding Natural Evolution Technology
5. Consumers Looking to Sustainable Food Production to Feed Global Population
6. Contour Products Introduces Groundbreaking Sleep Apnea, Respiratory and Ergonomic Body Comfort Pillows at Medtrade; Self-Explanatory Products Serve Customer Needs, Expand Retailers DME Offerings
7. Glycotex Reports First Patient Enrollment in Phase IIb Study of Lead Product Candidate GLYC-101 for Wound Healing
8. Sustainable Oils Names Scott Johnson as General Manager, Expands Management Team for Camelina Research and Production
9. Ventria Expands Lactoferrin Production
10. China Biologic Products Provides Preliminary Guidance for 2009 of Revenues of $90 to $100 Million and Net Income of $18 to 22 Million
11. Advanced Analytical Technologies, Inc. Expands Into New Office and Production Space

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/10/2009)... iSirona Appoints John Cooper as Chairma...ity, Fla. (PRWEB) November 10, 2009 -- iSirona®...ions for healthcare providers, today announced the...rd, effective October 21, 2009. He replaces Chairm...e to serve as the company,s CEO and retains a seat...
(Date:11/9/2009)...N, Nov. 9 The Appignani...ist Association, held a panel discussion today at ...merging technologies in biomedical sciences and cl...oreno and Andrew Light, both of the Center for Ame...ical and political angles. ,, A video of the e...
(Date:11/9/2009)..., Nov. 9 BioMed Realty T...company has received commitments from lenders to i...ne of credit by $65 million to an aggregate of $66...he facility. The weighted-average effective inter... as of September 30, 2009. The maturity date remai...
(Date:11/9/2009)..., Nov. 9 NexBio, Inc. announced th...ican College of Allergy, Asthma, and Immunology in...AS181 (Fludase®), a Sialidase, Decreases Airw...ects in Animal Models of Asthma". ,, DAS181 (Fl...m host-targeting drug candidate being studied in h...
Breaking Biology Technology:iSirona Selects New Chairman of the Board 2Jonathan Moreno and Andrew Light Speak About Biotechnology and Global Warming at the National Press Club 2Jonathan Moreno and Andrew Light Speak About Biotechnology and Global Warming at the National Press Club 3BioMed Realty Trust Receives Commitments to Expand Unsecured Line of Credit to $665 Million 2BioMed Realty Trust Receives Commitments to Expand Unsecured Line of Credit to $665 Million 3NexBio(R) Presents Data Showing Anti-Asthma Activity of DAS181 (Fludase(R)*) at ACAAI 2009 2NexBio(R) Presents Data Showing Anti-Asthma Activity of DAS181 (Fludase(R)*) at ACAAI 2009 3
...ver lands its first national retail drug ...pril 8, 2008 ALCiS Health, Inc., a,provider of pa...Walgreens,the nation,s largest drugstore chain, is... cream, ALCiS Daily Relief, at all of its 6,237 st...oss the United States marks the,product,s first na...
...perience in strategic and operational leadership ...future opportunities, ...nced,the appointment of Brad L. Stewart as Preside... company that develops and manufactures research a...ted technology to assay,cell-mediated immunity (CM...
...o Match Medicare Policy, SAN CARLOS, Calif., Apri...ervices (CMS) have approved at-home sleep testing,... had mandated that,suspected sleep apnea sufferers...olicy allows continuous positive airway pressure (...nosed via unattended home monitoring devices.,This...
Other Biology Technology:ALCiS(R) Daily Relief Now Available at Walgreens 2Cylex Announces Brad L. Stewart as President of the Company 2Medicare Approves in Home Sleep Apnea Testing 2
(Date:11/9/2009)...PHIA Scientists and industry leaders from around ...for the AACR-NCI-EORTC Molecular Targets and Cance...l feature groundbreaking information on important ... complex disease and to treat it effectively we ne...kes place at the molecular level," said Lewis Cant...
(Date:11/8/2009)...ON - (Nov. 8, 2009) The loss of a gene through de...ociated with significant abnormalities in learning...d by Baylor College of Medicine ( www.bcm.edu ) in... Nature Genetics . , "This research goes about ... a specific group of individuals to this gene," sa...
(Date:11/6/2009)...rate the 150th anniversary this month of the publi...nstitute of Biological Sciences (AIBS) is publishi...arles Darwin and his historic insights into evolut...e University of California, Berkeley, and James T....ticle, "Ten Myths About Charles Darwin," appeared ...
Breaking Biology News(10 mins):Developmental delay could stem from nicotinic receptor deletion 2Frost 26 Sullivan 3A Replacement of Old Equipment Boosts Kenyan Medical Imaging Industry 48242 1Frost 26 Sullivan 3A Replacement of Old Equipment Boosts Kenyan Medical Imaging Industry 48242 2Frost 26 Sullivan 3A Replacement of Old Equipment Boosts Kenyan Medical Imaging Industry 48242 3Frost 26 Sullivan 3A Replacement of Old Equipment Boosts Kenyan Medical Imaging Industry 48242 4Mayor Manny Diaz Commissioner Heyman Rep Brise Community Health Leaders and Healthcare Workers to Hold Press Conference to Push for Healthcare Ref 48240 1Mayor Manny Diaz Commissioner Heyman Rep Brise Community Health Leaders and Healthcare Workers to Hold Press Conference to Push for Healthcare Ref 48240 2Is this the beginning of the end of plant breeding 3F 8759 1Is this the beginning of the end of plant breeding 3F 8759 2Is this the beginning of the end of plant breeding 3F 8759 3
...mely small nanoscale particles are released by com...y outnumbering the previously detected, larger-siz...ding to new findings* by researchers at the Nation...o-called "ultrafine particles" (UFP) range in size...r vehicles and a variety of indoor sources and hav...
...f small and seemingly insignificant habitat patche...er certain circumstances, as a group, provide an a...itats. This finding can make preservation of impor...nd other heavily exploited areas. , The study by ...tment of Systems Ecology, and Stockholm Resilience...
...press release is available in German , , Duisbu...MA for short) - better known as acrylic glass - co...ars, alcohols or fatty acids. PMMA is manufactured...acterial strain, scientists at the University of D...mental Research (UFZ) have found an enzyme which c...
Other Biology News:Nanoparticles in the home: More and smaller than previously detected 2Networks of small habitat patches can preserve urban biodiversity 2Acrylic glass made of sugar 2Acrylic glass made of sugar 3
...) is a base medium for preparation of minimal and ...um sulfate but does not contain amino acids. Both ...le. Each pouch contains reagents to prepare 500 m...B for S. cerevisiae media. Store at 15C to 30C. Gu...
... family of human cullin genes (CUL-1, -2, -3, -4a,...53 gene. Cullin-3 is proposed to be a part of E3 p... with cyclin E and targets it for ubiquitination, ...in E is an activator of cdk2, which leads the cell...
Imject Freund's Incomplete Adjuvant (FIA) from Pierce Biotechnology, Inc.
Tyrode's Salts solution from Sigma-Aldrich
Biology Products: